Inventor · disambiguated record
Gyorgy F. Ambrus
Also filed as: AMBRUS GYORGY · AMBRUS GYORGY F
12 granted patents·13 pending applications·103 citations·filing 1991–2024
89Inventor score
Top patents by PatentIndex Score
25 records- 0193US7491383B2Compositions having enhanced pharmacokinetic characteristicsALLERGAN INC·Filed 2002·Granted Feb 17, 2009·56 cites·18 claims
- 0292US9289413B2Prostamide-containing intraocular implantALLERGAN INC·Filed 2014·Granted Mar 22, 2016·13 cites·3 claims
- 0391US9889142B2Prostamide-containing intraocular implantALLERGAN INC·Filed 2016·Granted Feb 13, 2018·7 cites·3 claims
- 0486US10668081B2Prostamide-containing intraocular implantALLERGAN INC·Filed 2018·Granted Jun 2, 2020·2 cites·9 claims
- 0586US2024148750A1Prostamide-containing intraocular implantALLERGAN INC·Filed 2023·Application pending·0 cites
- 0684US2024358714A1Prostamide-containing intraocular implantALLERGAN INC·Filed 2024·Application pending·0 cites
- 0777US8629185B27-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereofAMBRUS GYORGY F·Filed 2010·Granted Jan 14, 2014·7 cites·7 claims
- 0875US2022354865A1Prostamide-containing intraocular implantALLERGAN INC·Filed 2021·Application pending·0 cites
- 0972US2021085689A1Prostamide-containing intraocular implantALLERGAN INC·Filed 2020·Application pending·0 cites
- 1069US9242935B2(-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and useALLERGAN INC·Filed 2014·Granted Jan 26, 2016·1 cites·15 claims
- 1166US2010160380A1Therapeutic Salt Compositions and MethodsRUBINO MARK P·Filed 2009·Application pending·0 cites
- 1266US2010204279A1Therapeutic Salt Compositions and MethodsRUBINO MARK P·Filed 2009·Application pending·0 cites
- 1363US9321717B2Process for rapid identification and preparation of crystalline formsALLERGAN INC·Filed 2012·Granted Apr 26, 2016·1 cites·17 claims
- 1462US5276044ALeukotriene receptor antagonist and antihistamine complex pharmaceutical compositionsALLERGAN INC·Filed 1991·Granted Jan 4, 1994·16 cites·7 claims
- 1560US2007254923A1Therapeutic salt compositions and methodsRUBINO MARK P·Filed 2007·Application pending·0 cites
- 1659US9353079B2Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereofALLERGAN INC·Filed 2014·Granted May 31, 2016·0 cites·6 claims
- 1759US2007265311A1Therapeutic Salt Compositions and MethodsRUBINO MARK P·Filed 2007·Application pending·0 cites
- 1857US2011207780A1Therapeutic Salt Compositions and MethodsRUBINO MARK P·Filed 2010·Application pending·0 cites
- 1955US9387196B23-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoic acid in crystalline form and methods for use thereofALLERGAN INC·Filed 2014·Granted Jul 12, 2016·0 cites·18 claims
- 2054US9181176B27-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereofALLERGAN INC·Filed 2013·Granted Nov 10, 2015·0 cites·1 claims
- 2147US9540328B2(−)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and useALLERGAN INC·Filed 2015·Granted Jan 10, 2017·0 cites·11 claims
- 2247US2003045524A1Alpha-2-adrenergic agonist/fatty acid compositionsFiled 2002·Application pending·0 cites
- 2345US2002198210A1Alpha-2-adrenergic agonist/fatty acid compositionsALLERGAN SALES INC·Filed 2001·Application pending·0 cites
- 2445US2002198209A1Compositions having enhanced pharmacokinetic characteristicsALLERGAN SALES INC·Filed 2001·Application pending·0 cites
- 2544US2017087163A1Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereofALLERGAN INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gyorgy F. Ambrus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →